Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma.

Suehiro Y, Wong CW, Chirieac LR, Kondo Y, Shen L, Webb CR, Chan YW, Chan AS, Chan TL, Wu TT, Rashid A, Hamanaka Y, Hinoda Y, Shannon RL, Wang X, Morris J, Issa JP, Yuen ST, Leung SY, Hamilton SR.

Clin Cancer Res. 2008 May 1;14(9):2560-9. doi: 10.1158/1078-0432.CCR-07-1802.

2.

Associations of dietary methyl donor intake with MLH1 promoter hypermethylation and related molecular phenotypes in sporadic colorectal cancer.

de Vogel S, Bongaerts BW, Wouters KA, Kester AD, Schouten LJ, de Goeij AF, de Bruïne AP, Goldbohm RA, van den Brandt PA, van Engeland M, Weijenberg MP.

Carcinogenesis. 2008 Sep;29(9):1765-73. doi: 10.1093/carcin/bgn074. Epub 2008 Mar 13.

3.

Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample.

Ogino S, Kawasaki T, Kirkner GJ, Kraft P, Loda M, Fuchs CS.

J Mol Diagn. 2007 Jul;9(3):305-14.

4.

Aspirin and the risk of colorectal cancer in relation to the expression of COX-2.

Chan AT, Ogino S, Fuchs CS.

N Engl J Med. 2007 May 24;356(21):2131-42.

5.

Diet, lifestyle and risk of K-ras mutation-positive and -negative colorectal adenomas.

Wark PA, Van der Kuil W, Ploemacher J, Van Muijen GN, Mulder CJ, Weijenberg MP, Kok FJ, Kampman E.

Int J Cancer. 2006 Jul 15;119(2):398-405.

6.

Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism.

Glynn RJ, Rosner B.

Am J Epidemiol. 2005 Nov 15;162(10):975-82. Epub 2005 Oct 5.

7.

Sensitive sequencing method for KRAS mutation detection by Pyrosequencing.

Ogino S, Kawasaki T, Brahmandam M, Yan L, Cantor M, Namgyal C, Mino-Kenudson M, Lauwers GY, Loda M, Fuchs CS.

J Mol Diagn. 2005 Aug;7(3):413-21.

8.

Plasma vitamin B6 and the risk of colorectal cancer and adenoma in women.

Wei EK, Giovannucci E, Selhub J, Fuchs CS, Hankinson SE, Ma J.

J Natl Cancer Inst. 2005 May 4;97(9):684-92.

9.

The Nurses' Health Study: lifestyle and health among women.

Colditz GA, Hankinson SE.

Nat Rev Cancer. 2005 May;5(5):388-96. Review.

PMID:
15864280
10.

Folate, colorectal carcinogenesis, and DNA methylation: lessons from animal studies.

Kim YI.

Environ Mol Mutagen. 2004;44(1):10-25. Review.

PMID:
15199543
11.

Relationship of folate, vitamin B-6, vitamin B-12, and methionine intake to incidence of colorectal cancers.

Harnack L, Jacobs DR Jr, Nicodemus K, Lazovich D, Anderson K, Folsom AR.

Nutr Cancer. 2002;43(2):152-8.

PMID:
12588695
12.

Epidemiologic studies of folate and colorectal neoplasia: a review.

Giovannucci E.

J Nutr. 2002 Aug;132(8 Suppl):2350S-2355S. Review.

13.

The influence of folate and multivitamin use on the familial risk of colon cancer in women.

Fuchs CS, Willett WC, Colditz GA, Hunter DJ, Stampfer MJ, Speizer FE, Giovannucci EL.

Cancer Epidemiol Biomarkers Prev. 2002 Mar;11(3):227-34.

14.

Inverse relationship between microsatellite instability and K-ras and p53 gene alterations in colon cancer.

Samowitz WS, Holden JA, Curtin K, Edwards SL, Walker AR, Lin HA, Robertson MA, Nichols MF, Gruenthal KM, Lynch BJ, Leppert MF, Slattery ML.

Am J Pathol. 2001 Apr;158(4):1517-24.

15.

Risk factors for Ki-ras protooncogene mutation in sporadic colorectal adenomas.

Martínez ME, Maltzman T, Marshall JR, Einspahr J, Reid ME, Sampliner R, Ahnen DJ, Hamilton SR, Alberts DS.

Cancer Res. 1999 Oct 15;59(20):5181-5.

16.

A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, Srivastava S.

Cancer Res. 1998 Nov 15;58(22):5248-57. Review.

17.

Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study.

Giovannucci E, Stampfer MJ, Colditz GA, Hunter DJ, Fuchs C, Rosner BA, Speizer FE, Willett WC.

Ann Intern Med. 1998 Oct 1;129(7):517-24.

PMID:
9758570
18.

Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines.

Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H, Jessup JM, Kolodner R.

Cancer Res. 1997 Mar 1;57(5):808-11.

19.

Alcohol, low-methionine--low-folate diets, and risk of colon cancer in men.

Giovannucci E, Rimm EB, Ascherio A, Stampfer MJ, Colditz GA, Willett WC.

J Natl Cancer Inst. 1995 Feb 15;87(4):265-73.

PMID:
7707417
20.

Applying Cox regression to competing risks.

Lunn M, McNeil D.

Biometrics. 1995 Jun;51(2):524-32.

PMID:
7662841
Items per page

Supplemental Content

Write to the Help Desk